Other Current Assets - Arcus Biosciences Inc (NYSE:RCUS) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 15.67 USD -2.79%

Updated:

Arcus Biosciences Inc
Other Current Assets

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Arcus Biosciences Inc
Other Current Assets Peer Comparison

ABBV

GILD

AMGN

VRTX

REGN

Company		Other Current Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Arcus Biosciences Inc NYSE:RCUS	Other Current Assets $29m	CAGR 3-Years 49%	CAGR 5-Years 56%	CAGR 10-Years N/A
	Abbvie Inc NYSE:ABBV	Other Current Assets $4.6B	CAGR 3-Years 5%	CAGR 5-Years 21%	CAGR 10-Years 6%
	Gilead Sciences Inc NASDAQ:GILD	Other Current Assets $2.8B	CAGR 3-Years 14%	CAGR 5-Years 8%	CAGR 10-Years 10%
	Amgen Inc NASDAQ:AMGN	Other Current Assets $2.8B	CAGR 3-Years 7%	CAGR 5-Years 6%	CAGR 10-Years -1%
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	Other Current Assets $511.1m	CAGR 3-Years 15%	CAGR 5-Years 31%	CAGR 10-Years 31%
	Regeneron Pharmaceuticals Inc NASDAQ:REGN	Other Current Assets $414.9m	CAGR 3-Years 25%	CAGR 5-Years 18%	CAGR 10-Years 17%

See Also

Based on the financial report for Mar 31, 2024, Arcus Biosciences Inc's Other Current Assets amounts to 29m USD.

Over the last year, the Other Current Assets growth was 16%. The average annual Other Current Assets growth rates for Arcus Biosciences Inc have been 49% over the past three years , 56% over the past five years .

Join more than 141,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.